SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001214659-14-008339
Filing Date
2014-12-12
Accepted
2014-12-12 17:00:15
Documents
2
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 s12101410qa1.htm 10-Q/A 53450
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 305825
  Complete submission text file 0001214659-14-008339.txt   360288
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

IRS No.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-34637 | Film No.: 141284262
SIC: 2834 Pharmaceutical Preparations